The critical role for GATA family proteins in maintaining the normal (non-transformed) cell state is corroborated by the recent findings of mutations or methylation in GATA genes both in primary cancers and tumor lines including breast. Previously, microarray profiling studies determined that the highest expression of both GATA3 and ESR1 (estrogen receptor a) is seen in tumors associated with the most favorable survival outcomes, whereas the lowest expression of GATA3 is detected in tumor subtypes showing the worst outcomes. At this time, genes and pathways that are regulated by GATA3 in the mammary gland are not well defined. We have previously established a requirement for FOG (Friend Of GATA) cofactors during mouse development. Here we report that in the murine mammary gland Fog2 gene expression is upregulated upon pregnancy and lactation with prominent expression in the epithelial cells of the gland during post-lactational regression. Mammary-specific deletion of Fog2 identified a role for this gene during gland involution; excision of the Fog2 gene leads to the accelerated involution of the gland despite diminished levels of the remodeling enzymes. Importantly, the levels of several genes linked to the control of cancerous transformation in the breast (Esr1, Prg and Foxa1) are significantly reduced upon Fog2 excision. This implicates FOG2 in the maintenance of epithelial cell differentiation in the mammary gland and in performing a protective role in breast cancer.
The critical role for GATA family proteins in maintaining the normal (non-transformed) cell state is corroborated by the recent findings of mutations or methylation in GATA genes both in primary cancers and tumor lines including breast. Previously, microarray profiling studies determined that the highest expression of both GATA3 and ESR1 (estrogen receptor a) is seen in tumors associated with the most favorable survival outcomes, whereas the lowest expression of GATA3 is detected in tumor subtypes showing the worst outcomes. At this time, genes and pathways that are regulated by GATA3 in the mammary gland are not well defined. We have previously established a requirement for FOG (Friend Of GATA) cofactors during mouse development. Here we report that in the murine mammary gland Fog2 gene expression is upregulated upon pregnancy and lactation with prominent expression in the epithelial cells of the gland during post-lactational regression. Mammary-specific deletion of Fog2 identified a role for this gene during gland involution; excision of the Fog2 gene leads to the accelerated involution of the gland despite diminished levels of the remodeling enzymes. Importantly, the levels of several genes linked to the control of cancerous transformation in the breast (Esr1, Prg and Foxa1) are significantly reduced upon Fog2 excision. This implicatesIntroduction Multi-zinc finger FOG (Friend Of GATA) proteins play critical roles in mammalian development and the differentiation of multiple lineages (reviewed in Cantor and Orkin, 2005) . FOG proteins (FOG1 and FOG2) are cofactors for the GATA family of transcriptional regulators; FOG proteins are intimately linked with GATA function (Tsang et al., 1997; Crispino et al., 1999; Lu et al., 1999; Svensson et al., 1999; Tevosian et al., 1999 Tevosian et al., , 2002 .
Currently there is no proof of FOG2 involvement in mammary gland development or breast cancer. The essential role for GATA family proteins in maintaining the normal non-transformed state of the cells is corroborated by recent findings of mutations (Lacroix and Leclercq, 2004; Usary et al., 2004) or methylation (Akiyama et al., 2003) of GATA genes both in primary cancers and tumor lines. Mutations of GATA1 in Down syndrome myeloid leukemogenesis provide support for the hypothesis that mutations of GATA factors occur early in cancer (Wechsler et al., 2002; Mundschau et al., 2003; Crispino, 2005) . Finally, several studies have already implicated GATA proteins as potential tumor suppressors in various tissues, including the mammary gland (Bertucci et al., 2000 (Bertucci et al., , 2004 Lacroix and Leclercq, 2004; Usary et al., 2004; Shen et al., 2005) . In particular, microarray profiling studies have shown that GATA3 is highly expressed in a subset of human breast tumors (Perou et al., 2000; Gruvberger et al., 2001; West et al., 2001; van't Veer et al., 2002) and that GATA3 expression in breast tumors highly correlates with the expression of the estrogen receptor a-gene/protein (ESR1) (Hoch et al., 1999; van de Rijn et al., 2002) . Analysis of 115 breast tumor samples confirmed that expression of GATA3 correlated with the expression of a subset of genes considered important in breast luminal epithelial function (Sorlie et al., 2003) . Importantly, the highest expression of GATA3 and ESR1 is seen in tumors of the 'luminal A' subtype, which is associated with the most favorable survival outcomes (Parikh et al., 2005) . The lower expression of GATA3 and ESR1 is characteristic of the 'luminal B' ER þ subtype, which is associated with poor survival; the lowest expression of GATA3 is seen in 'HER2 þ ' and 'basal-like' tumor subtypes, which show the worst outcomes (Sorlie et al., 2003; Mehra et al., 2005; Parikh et al., 2005) . Somatic mutations of GATA3 have been identified in five breast tumors (and not in 192 control individuals (388 chromosomes)) (Usary et al., 2004) . Despite these important advances we do not yet understand which genes and pathways are regulated by GATA3, or FOG2, or both in the mammary gland.
In our inspection of the mice harboring a knock-in of the b-galactosidase marker gene in the Fog2 locus (Manuylov et al., submitted), we noted a prominent Fog2 expression in the pregnant and involuting mammary glands. To identify the processes and cells that require FOG2 protein for their function, we deleted the Fog2 gene specifically in the luminal mammary epithelium. Here, we characterize the morphology and gene expression in the mammary gland following conditional deletion of the Fog2 gene. We report here a premature mammary gland involution in female mice homozygous for a loss-of-function mutation in the Fog2 gene that correlates with a reduction in the expression of Bcl2 proto-oncogene. Although gene expression pattern in the involuted glands in the Fog2 mutant mice remains largely intact, the Esr1 and Foxa1 gene expression levels are significantly downregulated; the level of ESR1 protein is also reduced. These data implicate FOG2, a cofactor for GATA family proteins, in the transcriptional control of gene expression in mammary gland.
Results

Fog2 expression in the mammary gland
To examine Fog2 expression we generated a FOG2-LacZ-eGFP line of mice. In these animals the lacZ gene is incorporated ('knocked-in') into the Fog2 locus to allow b-galactosidase expression as a fusion protein inframe with the first 235 amino acids of the FOG2 protein. This creates a null allele of Fog2 (Manuylov et al., submitted). Unexpectedly, in our analysis of Fog2 expression in neonatal animals we observed a pronounced X-gal staining in epidermal appendages (hair follicles and teeth primordia) that was confirmed by anti-FOG2 antibody staining (data not shown). Since a number of genes that are known to play a role in hair and teeth development are also involved in mammary gland morphogenesis we examined Fog2 expression in the mammary gland.
Fog2 expression during mouse mammary gland development appears to be highly dynamic. In the virgin gland Fog2 level is very low ( Figure 1a) ; however, during pregnancy, lactation and involution a pronounced X-gal staining of the whole-mount gland preparation could be observed (Figure 1b-d) . Histological evaluation of the X-gal-stained tissue confirmed that in the virgin gland stromal fibroblasts of the gland as well as the vasculature were Fog2 positive, whereas during pregnancy Fog2 expression appears in the myoepithelial cells (Figure 2a and b) . Upon lactation, X-gal staining could be clearly observed in whole-mount preparations of the gland in myoepithelial cells of the alveoli (Figure 2c-d) . To ascertain that X-gal staining faithfully mimics the expression of the FOG2 protein in the myoepithelium, the lactating gland preparations were reacted with antibody that recognizes the Nterminal region of the FOG2 protein (Figure 2e ).
In the involuting gland, Fog2 expression appears in the luminal epithelial cells by the second day and by day four of involution Fog2 is strongly expressed in the remnants of the collapsed lobular/alveolar structures (epithelial cords/clusters) that are surrounded by adipocytes (Figure 3a-c) . It also continues to be expressed in the myoepithelium surrounding these clusters. Upon completion of the remodeling and clearance of the alveolar remnants, Fog2 expression nearly disappears, although it can still be easily detected on day 10 of involution ( Figure 3d ).
Targeted excision of Fog2 in the mammary gland
We determined that Fog2 is highly expressed in the mammary epithelium of the gland during the involution stage. As strong and specific promoters are available to express Cre recombinases in the lactating mammary epithelium, it is possible to examine the consequences of Fog2 gene loss in this cell population. We used a whey acidic protein (WAP)-Cre line of animals available from the NIH-NCI Frederick Mouse Repository. WapCre recombinase is activated upon lactation specifically in luminal mammary epithelium (Wagner et al., 1997 (Wagner et al., , 2001 . We reasoned that the WapCre-mediated excision of the Fog2 gene should permit studying the consequences of Fog2 ablation in luminal breast epithelium.
To examine the consequences of tissue-specific Fog2 gene loss, a conditionally targeted line of mice, Fog2 flox/flox , has been generated. Fog2 flox/flox animals are fully viable and fertile and exhibit no obvious abnormalities. . To confirm the excision of Fog2 we performed a Southern-blot analysis with DNA extracted from the mammary gland of WapCreFog2 flox/À females after completion of lactation ( Figure 4 ). As expected from the previously published data, we detected a considerable amount of the deleted allele in the mammary gland thus confirming that the gene is excised (the non-deleted allele is likely contributed by the nonluminal cells). We also examined a loss of FOG2 at the protein level to confirm that while FOG2 is retained in the myoepithelial cells (that do not express WapCre), the luminal cells are no longer positive for FOG2 expression (Figure 5a -f).
WapCreFog2 flox/À mice became pregnant and were fertile and able to support the normal size litters during lactation (data not shown), so pregnancy and lactation are not obviously affected by the absence of Fog2 in mammary epithelial cells. We also performed histological evaluation of the mammary glands in the pregnant 
Fog2 is required for normal mammary gland involution
We compared the mammary gland samples of the control mice (Fog2
) with the glands of experimental (WapCreFog2 flox/À ) mice, where Fog2 is excised on days 3, 4 and 6 of involution (I). We observed that in the experimental sample involution occurs faster on both days I3 and I4 compared with the control samples. Whereas at I3 the control gland still consists mainly of distended alveoli, the fat tissue is already reappearing (lipid is accumulating) in the excised gland (Figure 6a-d) . Similarly, while the control gland on I4 contained some distended alveoli, in the Fog2-excised sample the alveoli have completely collapsed into clusters of epithelial cells (Figure 6b -e) and the area containing adipocytes has greatly expanded (Figure 7a-b) . To examine the apoptosis we compared the samples of the Fog2-deleted and control gland at day 3 of involution (before the bulk of the cells is cleared from the control gland). We also observed a slight increase in the amount of apoptotic cells (scored both by the histological appearance of apoptotic bodies on the HandE sections (data not shown) and by the TUNEL assay) in the Fog2-deleted gland that, however, was not statistically significant (Figure 7c-e) . Cell proliferation (defined as the % of the PCNA (proliferating cell nuclear antigen)-positive cells) in Fog2-deleted I3 glands was found to be similar to the control sample (data not shown). After 6 days of involution no differences could be observed between the experimental and the control samples (Figure 6c-f) .
Analysis of the gene expression changes upon Fog2 ablation
In an effort to understand the downstream events involved in the regulation of cell survival by Fog2, we analysed several potential signaling pathways and target genes (Supplementary Table 1 ). Quantitative real-time polymerase chain reaction (qRT-PCR) analysis confirmed that Fog2 expression in the mammary gland is at its peak on days 3 and 4 of the involution (data not shown). Hence, in our analysis of the WapCre-induced Fog2 deletion we compared the Fog2-excised glands with controls at this stage. WapCre excision leads to a significant reduction in Fog2 expression in the glands on both days ( Figure 8a) ; the remaining Fog2 expression is likely a product of myoepithelial cells that do not express WapCre (see Figures 4 and 5) .
We examined the expression of the genes that are involved in the regulation and execution of apoptosis and survival; we also queried genes that have been implicated in both the first and the second stage of the involution (e.g. IGF and TGF-b pathways; Clu (clusterin); Mmp3 (matrix metalloproteinase)). qRT-PCR À (null) allele is not detectable by this analysis and was independently confirmed by second probe as previously described (Tevosian et al., 2000) (data not shown).
Fog2 function in the mammary gland development NL Manuylov et al revealed that in the WapCreFog2 flox/À glands expression of most genes was not altered significantly compared with the control samples; however, statistically significant changes have been observed for several others (e.g. Bcl2 and Bax, caspase 3 (Casp3), metalloproteinase Mmp2, the plasminogen activator urokinase and its receptor (Plau(uPA) and Plaur)) (Supplementary Table 1 and Figure 8b) .
Previous work has established a link between the FOG2 protein partner GATA3 and ESR1 as well as two other transcription factors, FOXA1 (HNF3A) and XBP1 (e.g. Lacroix and Leclercq, 2004; Laganiere et al., 2005; Eeckhoute et al., 2006) . Hence, we also examined the effect of Fog2 deletion on these genes' expression. We observed a statistically significant reduction in both estrogen and progesterone receptor RNA expression in the Fog2-deleted gland ( Figure 8c) ; the level of Foxa1 expression was dramatically (B4 times at I4) reduced, whereas Xbp1 was downregulated only slightly (Figure 8d ). To confirm that the difference in RNA expression translates into a reduced protein level we examined the ESR1 expression in the frozen sections in the control and Fog2-deleted mammary gland on day 4 of involution. We observed a significant decrease in ESR1 expression in the Fog2-deleted gland (Figure 9 ). We conclude that FOG2 is essential for the regulation of ESR1 expression in mammary epithelial cells during gland involution.
Discussion
To examine the mechanism of Fog2 function in involution we compared gene expression in the control and Fog2-excised mammary glands. We demonstrate here that ablation of GATA cofactor FOG2 in mammary epithelium results in the significantly reduced level of Esr1 and Pgr RNA expression as well as decreased ESR1 protein expression in these cells. We also observe a dramatic downregulation of expression for another transcription factor, Foxa1, upon Fog2 excision. We hence propose that FOG2 is required to control (upregulate) Esr1 and Foxa1 expression in the epithelial cells of the breast. Since our previous work has established an essential requirement for a FOG/GATA partnership, we also hypothesize that it is a GATA/ FOG complex that maintains the differentiated state of a breast epithelium and that inactivation/downregulation of either gene could lead to downregulation of Esr1 and Foxa1 expression. Gata3 expression in the mammary epithelium during involution was previously described (Master et al., 2002) ; however, other GATA family members (e.g. GATA4 and GATA6; Huggins et al., 2006) are expressed in the gland as well. It is Fog2 function in the mammary gland development NL Manuylov et al important to emphasize that FOG2 is likely to serve as a common cofactor for all/any GATA proteins; hence eliminating Fog2 will interfere with Fog-dependent functions of GATA proteins even in tissues where multiple members of the GATA family play redundant roles. Recent data underscored the importance of epithelial (and not stromal) ESR1 for proliferation and morphogenesis in the mammary gland (Booth and Smith, 2006; Mallepell et al., 2006) . Although the positive correlation between the Gata3 expression and Esr1 expression in the breast has been well documented, the exact nature of the relationship between Gata3 and Esr1 is not known. Our data suggest that GATA/FOG complex is upstream and is able to regulate Esr1 expression during the involution stage. While the function of estrogen in mammary epithelium viability is overall well established (e.g. see Jordan, 2004 for review), estrogen pathway contribution to cell survival specifically during the involution stage is not well understood. Based on the essential role estrogen plays in breast function it is likely, however, that reduction in the Esr1/Pgr levels is a contributing factor in the decreased viability of Fog2-null epithelial cells.
In contrast to the long-term protective effect of pregnancy, pregnancy is associated with a short-term increase in breast cancer risk in young women. Furthermore, breast cancer that is diagnosed shortly after a woman gives birth has a worse clinical prognosis than tumors not associated with a recent pregnancy. It has been suggested that remodeling of the cellular microenvironment during pregnancy and involution may contribute to the enhanced invasive and metastatic potential of breast carcinomas and worsen the clinical outcome (see Polyak, 2006 for review). We hypothesize that involution could be a particularly vulnerable stage during the pregnancy cycle, and the inability of GATA3/FOG2 complex (e.g. due to mutation in either gene) to maintain the differentiated state of the luminal epithelium in the face of extensive tissue remodeling during involution could be the initial step in cancerous transformation. The differences in the RNA level that we observe are likely due to changes in the gene expression program in the absence of Fog2; they are not simply the consequences of the decrease in the cell number in the excised gland. Indeed, the expression of several genes flox/À glands indicating that the expression differences we observe for other genes (e.g. Esr1 and Foxa1) are not solely due to the decrease in epithelial cell count upon Fog2 excision.
The acceleration of involution coincides with the decrease in the expression of Bcl2 proto-oncogene upon Fog2 deletion. Although Bcl2 was shown to promote epithelial cell survival in the gain-of-function experiments in the gland (Murphy et al., 1999; Schorr et al., 1999) its role in the control of apoptosis during the early phase of normal involution process may be limited (Metcalfe et al., 1999; Schorr et al., 1999) . Nevertheless, we cannot exclude that a decrease in Bcl2 gene expression in the WapCreFog2 flox/À mice is a contributing factor that leads to an accelerated involution in these animals. Recent work suggests that cardiac expression of Bcl2 is directly regulated by a GATA family member (GATA4) in vivo, although the role of FOG2 has not been explored (Kobayashi et al., 2006) . Other Bcl2 family genes we have examined (see Supplementary  Table 1) , both proapoptotic and death suppressors, are not affected by Fog2 excision.
Epithelial Fog2 expression is limited to the involution stage of mammary development and WapCre-mediated ablation of Fog2 accelerates mammary gland involution. Fog2 excision likely affects both the cell survival and remodeling in the involuting mammary gland. Despite accelerated involution in the Fog2-excised glands, the expression of the remodeling proteolytic enzymes is downregulated in the absence of Fog2. This could be explained by a separate role GATA/FOG2 transcription complex plays in the regulation of these genes as GATA family members have been implicated in metalloproteinase gene upregulation (Han et al., 2003) . Alternatively, it is possible that the mammary glands from the Fog2-excised animals are downregulating pathways involved in tissue remodeling in an attempt to compensate for the increased number of epithelial cells undergoing apoptosis.
Our studies have potential implications for human disease. We hypothesize that Fog2 is essential in maintaining the differentiated state of the mammary luminal epithelium. Although this remains to be proven experimentally, the loss of Fog2 is likely to increase the pool of Esr1-negative cells that could be targeted by an oncogenic event leading to a more severe clinical outcome. The relatively low level of Fog2 RNA in the mammary gland (which is substantially lower than that of Gata3 (our unpublished observations)) may have precluded the detection of Fog2 differential expression by microarray profiling screens; however, our results suggest that the status of the Fog2 gene in tumor samples should be evaluated for possible mutations and/ or expression abnormalities. Further studies will address the mechanisms of GATA/FOG2 action during involution and should afford new insights into how the GATA/FOG-regulated pathways are corrupted in cancer.
While this work was under review, Werb and coworkers (Kouros-Mehr et al., 2006) described the animals with the conditional knockout of Gata3 in mammary epithelium. Although the consequences of Gata3 gene ablation are more severe than that of Fog2, Kouros-Mehr et al. (2006) also placed Esr1 and Foxa1 downstream of GATA3 and demonstrated that FOXA1 promoter binds GATA3 in vivo. Hence it is likely that these genes are regulated by the GATA3/FOG2 complex, whereas other prospective GATA3 target genes (e.g. Xbp1) do not require Fog2. Additionally, the recently published study adds to a framework for understanding the role of FOXA1 in the mammary gland as it highlights its role as a growth inhibitor and a favorable prognostic factor in human breast cancer (Wolf et al., 2006) . Thus, Fog2 is required for normal expression of two genes (Esr1 and Foxa1) that are correlated with a favorable outcome in breast cancer.
Materials and methods
Animals
To generate animals with a conditionally targeted Fog2 locus we performed a homologous recombination in the ES cells. The first LoxP site was introduced into the XhoI site in the seventh intron and the second LoxP site into the XbaI site of the 3 0 downstream sequence in the Fog2 locus (Zfpm2, Ensembl database); the details of the construct are available upon request. WapCre mice were obtained from the NIH Repository and were maintained on their original C57BL/6NCr background. Fog2LacZiresEGFP mice (Manuylov et al., submitted) and Fog2 þ /À heterozygous mice (Tevosian et al., 2000) were maintained on a mixed 129/C57BL/6J background. For expression studies Fog2LacZiresEGFP males were crossed with the C57BL6/6J females. As variations in mouse genetic background are known to affect the involution (e.g. Thangaraju et al., 2004), we followed a standard mating scheme to generate ) and control (Fog2 À/flox ) female siblings. For involution experiments these females were bred to the wild-type males. To equalize the lactation pressure, the number of pups for each dam was adjusted to six and maintained through the lactation period. For analysis of the involuting gland the dams were allowed to nurse (lactate) for a total of 10 days at which time the pups were removed; 2, 3, 4, 6 and 10 days later the mice were euthanized and the glands removed for analysis. For the analysis of the lactating glands mice were euthanized and glands removed on day 10 of lactation. Mammary tissue was snap frozen in liquid nitrogen for DNA/RNA extraction, frozen in the OCT compound (VWR, West Chester, PA, USA) for both antibody staining and TUNEL assay or fixed in formalin/glutaraldehyde mix for the whole-mount X-gal staining.
Mouse genotyping
Mice were genotyped both by PCR and Southern-blot analysis using genomic DNA prepared from tail snips. Fog2 À (null) allele was detected by a Southern-blot analysis as described previously (Tevosian et al., 2000) . Whole-mount X-gal staining Whole-mount X-gal staining was performed as previously described (Adameyko et al., 2005) overnight at 371C. 10 mM thick tissue sections were cut on the microtome (Olympus, Center Valley, PA, USA) and floated onto SuperFrost þ slides and stained with haematoxylin and eosin (Richard Allan Scientific, Kalamazoo, MI, USA).
Detection of apoptotic cells
Mammary glands were dissected at I3 and apoptotic cells were detected by terminal deoxynucleotide UTP nick-end labeling (TUNEL), using an In Situ Cell Death Detection kit (Roche, Indianapolis, IN, USA). Nuclei were counterstained with Vectashield with DAPI (Vector, Burlingame, CA, USA). TUNEL-positive epithelial nuclei were counted in 10 random microscopic fields. Three mice of each genotype (Fog2 flox/À and WapCre Fog2 flox/À ) were analysed.
Total RNA extraction RNA was extracted using TRIZOL (Invitrogen, Carlsbad, CA, USA); lymph nodes were removed and mammary tissue was homogenized in liquid nitrogen. Isolated RNA was further cleaned with RNAeasy columns (Qiagen, Valencia, CA, USA). A first strand cDNA synthesis kit (Invitrogen) was used for cDNA preparation from 2 mg of total RNA.
Quantitative Real Time RT-PCR
The RT-PCR was performed using a PCR SYBR Green I Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions in a 7500 fast RT-PCR system machine and a standard amplification protocol was established for each gene. A standard curve for the Fog2 gene was generated from serial dilutions of a plasmid (Tevosian et al., 1999) containing a full-length Fog2 cDNA; calibration points for serial dilutions of the plasmids were from 10 6 to 10 2 copies. For the rest of the tested genes calibration curves were generated using a gel-purified RT-PCR product; dilution for calibration points was as described above. The value for each gene was normalized to the Gapdh gene value and these rations were compared between the control and the Fog2 mutant mammary sample. Gene copy number was calculated with ABI SDS Software Version 1.3.1. Values from at least three independent experiments were compared; standard deviation and a Student's t-test were calculated using Excel (Microsoft, Redmond, WA, USA).
Immunohistochemistry and immunofluorescence
Sections of the frozen glands were cut on the cryostat (Leica, Bannockburn, IL, USA). For FOG2 protein detection slides were reacted with goat anti-FOG2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and stained with antigoat Alexa Flour 555 (Molecular Probes, Carlsbad, CA, USA). Slides were mounted in Vectashield with DAPI (4 0 ,6-Diamidino-2-phenylindole, Vector) and photographed. For PCNA staining, an anti-PCNA antibody (AbCam, Cambridge, MA, USA) was used. PCNA-positive epithelial nuclei were counted in 10 random microscopic fields. Three mice of each genotype (Fog2 flox/À and WapCre Fog2 flox/À ) were analysed. For the immunodetection of the ESR1 protein slides were reacted with the rabbit anti-ESR1 antibody (AbCam) followed by anti-rabbit HRP-conjugated antibody (Bio-Rad, Hercules, CA, USA). Slides were stained using a DAB kit (Vector).
